Charles River Laboratorie (CRL) Misses Q2 EPS by 1c; Extends Agreement with AstraZeneca (AZN)
Go back to Charles River Laboratorie (CRL) Misses Q2 EPS by 1c; Extends Agreement with AstraZeneca (AZN)| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 2,937,806 | |||||
| CHARLES RIVER LABORATORIE (NYSE: CRL) | Delayed: 279.01 +0.95 (0.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $278.06 | 52 Week High | $89.18 | |||
| Open | $279.37 | 52 Week Low | $65.70 | |||
| Day High | $281.63 | P/E | 129.77 | |||
| Day Low | $275.88 | EPS | $2.15 | |||
| Volume | 952,919 | |||||
